Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shigetomi

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertensionO Kuchel, S Shigetomi
Nihon Naibunpi Gakkai Zasshi|January 20, 1980
[Studies on the blood pressure control mechanism in essential hypertension: the relation of plasma norepinephrine concentrations to plasma renin activity and haemodynamics (author's transl)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[Homovanillic acid (HVA)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3-Methoxy-4-hydroxyphenylglycol (MHPG)]S Shigetomi, S Fukuchi
Hypertension (Dallas, Tex. : 1979)|June 1, 1992
Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patientsO Kuchel, S Shigetomi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1992
[Potassium-sparing diuretics]S Shigetomi, S Fukuchi
American Journal of Hypertension|January 1, 1993
Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediableS Shigetomi, O Kuchel
Fukushima Journal of Medical Science|December 1, 1994
Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertensionS Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3,4-Dihydroxyphenylalanine (DOPA)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3,4-Dihydroxyphenylacetic acid (DOPAC)]S Shigetomi, S Fukuchi
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 1, 1995
Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertensionO Kuchel, S Shigetomi
Nihon Naibunpi Gakkai Zasshi|January 20, 1980
[Studies on the blood pressure control mechanism in essential hypertension: the relation of plasma norepinephrine concentrations to plasma renin activity and haemodynamics (author's transl)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[Homovanillic acid (HVA)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3-Methoxy-4-hydroxyphenylglycol (MHPG)]S Shigetomi, S Fukuchi
Hypertension (Dallas, Tex. : 1979)|June 1, 1992
Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patientsO Kuchel, S Shigetomi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 1, 1992
[Potassium-sparing diuretics]S Shigetomi, S Fukuchi
American Journal of Hypertension|January 1, 1993
Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediableS Shigetomi, O Kuchel
Fukushima Journal of Medical Science|December 1, 1994
Recent aspect of the role of peripheral dopamine and its receptors in the pathogenesis of hypertensionS Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3,4-Dihydroxyphenylalanine (DOPA)]S Shigetomi, S Fukuchi
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 1, 1995
[3,4-Dihydroxyphenylacetic acid (DOPAC)]S Shigetomi, S Fukuchi
Pageof 7